Table 2.
Braak 1/2, N = 46 |
Braak 3/4, N = 153 |
Braak 5/6, N = 463 |
||||
---|---|---|---|---|---|---|
Women | Men | Women | Men | Women | Men | |
Number (% of Braak subgroup) | 24 (52) | 22 (48) | 67 (44) | 86 (56) | 198 (43) | 265 (57) |
Age (years)c | 84.9 (7.6) | 84.4 (7.9) | 85.9 (7.9) | 83.7 (7.5) | 82.9 (8.3)* | 80.2 (8.1) |
Education (years)c | 15.0 (2.2) | 15.1 (3.7) | 15.1 (2.6) | 15.5 (3.3) | 14.2 (2.7) | 16.0 (3.0)* |
Number of (%) APOE ε4 carriers | 6 (25) | 6 (27) | 32 (48) | 41 (48) | 114 (58) | 165 (62) |
Race (% white) | 100 | 95.5 | 98.5 | 93.0 | 89.9 | 95.5 |
Time between last clinical visit and death (years) | 1.0 (0.8) | 0.9 (0.8) | 1.0 (0.9) | 1.3 (0.9) | 1.9 (1.4) | 1.8 (1.3) |
LM Immediatea,b | 13.8 (5.3)* | 8.0 (5.7) | 8.7 (6.0)* | 6.0 (5.7) | 2.5 (3.7) | 2.2 (3.0) |
LM Delaya,b | 12.5 (6.0)* | 7.1 (6.3) | 7.4 (6.2)* | 4.9 (5.8) | 1.3 (3.3) | 1.2 (2.6) |
Cells are formatted as mean (SD) unless otherwise noted.
Significant sex difference (P < 0.05) in the Braak 1/2 subgroup.
Significant sex difference (P < 0.05) in the Braak 3/4 subgroup.
Significant sex difference (P < 0.05) in the Braak 5/6 subgroup.
*Asterisk indicates higher value for women than men in that Braak category.